search
clinical researchers
Trends
- 1
A new report argues that the booming longevity industry โ anti-ageing treatments, supplements and clinics โ is growing faster than the scientific evidence supporting its claims. The piece warns that consumers are being sold promises of extended healthy lifespan before researchers have proven the underlying biology. It calls for stronger scrutiny of a market driven more by hope and investment than by clinical results.
- 2Clinical Trial Data Exposed in Academic Database BreachesโClinical trial data including genetic and medical history information has been exposed in academic research database bre
Breaches of academic research databases have exposed clinical trial data, including genetic and medical history information, affecting thousands of study participants. Privacy advocates are urging those affected to exercise their HIPAA rights by requesting their medical records and a list of everyone those records were shared with, and to correct any errors. The incident has renewed concerns about how research institutions safeguard sensitive participant data.
- 3Scientists Identify New Potential Target for Hypertension TreatmentโผScientists Discover a New Potential Treatment Target for High Blood Pressure
Researchers have identified a new potential treatment target for high blood pressure, a condition affecting over a billion people worldwide and a leading risk factor for heart disease and stroke. The discovery could open the door to new drug development beyond existing blood pressure medications. Details of the findings and their clinical significance remain limited.
- 4Highlights from World Cancer Congress 2026, Part TwoโผHighlights from World Cancer Congress 2026 โ Part 2
Part two of a roundup of highlights from the World Cancer Congress 2026 has been published, covering key presentations, research findings and discussions from the global oncology meeting. The continued coverage suggests sustained interest in developments presented at the congress among cancer researchers and clinicians worldwide.
- 5Epigenetic Editing Moves Closer to Clinical UseโEpigenetic Editing Steps Closer to the Clinic as Bioengineering Tools Mature
Epigenetic editing, which alters gene activity without changing DNA sequence, is reported to be advancing toward clinical application as bioengineering tools mature. The development suggests researchers are getting closer to therapies that could switch genes on or off to treat disease, a potentially safer alternative to DNA-cutting technologies like CRISPR gene editing.
- 6Blood test distinguishes bacterial from viral infections in newbornsโผBlood test shows whether newborns with fever have bacterial or viral infection
Researchers have developed a blood test that can show whether a newborn with a fever has a bacterial or a viral infection. The advance could help doctors decide quickly whether infants need antibiotics, reducing unnecessary treatment and speeding up care for babies with serious bacterial illness. Medical outlets are reporting on the test's potential to improve diagnosis in newborns, a group in whom infections are hard to distinguish and can become dangerous fast.
- 7Longevity boom is running ahead of the scienceโThe longevity boom is getting ahead of the science https://www. aljazeera.com/opinions/2026/9/ 27/the-longevity-boom-is-
An Al Jazeera opinion piece argues that the booming longevity industry โ anti-ageing treatments, supplements and clinics โ is outpacing the scientific evidence behind it. The author warns that commercial hype around extending lifespan is promoting products and promises before rigorous research has validated them, urging caution from consumers and stronger oversight of a rapidly growing wellness market.
- 8Psychedelic Drugs Market Set to Grow Through 2035โPsychedelic Drugs Market Forecast to 2035: Demand Accelerates on Mental Health Crisis and Regulatory Breakthroughs
A new market forecast projects the psychedelic drugs market to expand through 2035, driven by rising demand for mental health treatments and regulatory breakthroughs in approving psychedelic-based therapies. Industry analysts say growing acceptance of substances like psilocybin and MDMA for conditions such as depression and PTSD is attracting investment, though clinical and legal hurdles remain ahead of widespread adoption.
- 9Scientists explore growing replacement teeth to regrow lost onesโผLost a tooth? Science may one day grow it back
Research into tooth regeneration is drawing attention, with reports suggesting science may one day allow people to regrow lost teeth instead of relying on implants or dentures. The work builds on studies of stem cells and the biological mechanisms that form teeth during development, raising hopes for future clinical treatments.
- 10Could age explain conflicting psychedelic study results?โCould age help explain why psychedelic studies reach different conclusions?
Researchers are examining whether participants' age may help explain why psychedelic studies reach different conclusions. Older adults may respond differently to psychedelic therapies than younger participants, which could account for variability across trials. The question matters as psychedelics move closer to regulated clinical use for depression and other mental health conditions.